Table 3. Treatment-related toxicities.
Adverse events | Grade 1/2 | Grade3/4 | ||
---|---|---|---|---|
No. | % | No. | % | |
Hematologic | ||||
Leukopenia | 9 | 37.50 | 14 | 58.33 |
Neutropenia | 5 | 20.83 | 18 | 75.00 |
Anemia | 14 | 58.33 | 9 | 37.50 |
Thrombocytopenia | 6 | 25.00 | 11 | 45.83 |
Nonhematologic | ||||
Nausea/vomiting | 14 | 58.33 | 7 | 29.17 |
ALT/AST elevation | 14 | 58.33 | 1 | 4.17 |
Increased BUN | 2 | 8.33 | 0 | -- |
Heighten of hemodiastase | 0 | |||
Increased urinary amylase | 0 | |||
Coagulation disorders | ||||
APTT elongation | 12 (50.00%) | |||
Hypofibrinogenemia | 14 (58.33%) |